ACG to set up Asia's largest capsule plant in Maharashtra

Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada

Mumbai-based ACG has signed an Memorandum of Understanding (MoU) with the government of Maharashtra to set up Asia’s largest manufacturing plant cum R&D centre at Aurangabad in Maharashtra, to produce 40 billion capsules a year. The plant will serve both, Indian and international pharmaceutical and nutraceutical companies.

Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada. The state government has accorded it the status of a mega project.

Karan Singh, Managing Director, ACG, says, “Our vision to be a future-ready solutions provider to the pharma industry anywhere in the world and our proposed investment of approximately US $ 100 million (over Rs 600 crores) in this state-of-the-art plant, is an integral part of ACG’s mission to double our capsule manufacturing capacity to 240 billion capsules a year.”

The proposed plant will employ key design principles from the internationally recognised Leadership in Energy and Environmental Design (LEED) and will be powered significantly by green renewable energy to create and sustain value. Setting new benchmarks for the industry will employ automation and industry 4.0 technologies to minimise resource intensity and ensure products meet and exceed the highest global manufacturing practices (GMP).

According to Nitin Desai, Senior Vice President, ACG, “We have a long history of operating in Maharashtra and are privileged to sign this MOU with Government of Maharashtra for this mega project which when ready by 2023 will create around 1000 direct and indirect jobs in the region.”

Founded in Mumbai in 1961, ACG now serves pharmaceutical and nutraceutical companies all over the world, touching almost every aspect of solid dosage manufacturing